” content_phone=”<\/p>\n
Healthcare Professionals Hub<\/span><\/a><\/p>\n ” content_last_edited=”on|phone” admin_label=”Text” _builder_version=”4.27.2″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#ea5504″ text_orientation=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”||||false|false” link_option_url_new_window=”on” text_text_color_tablet=”” text_text_color_phone=”” text_text_color_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Healthcare Professionals Hub<\/span><\/a><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ admin_label=”Column” _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_3″ admin_label=”Column” _builder_version=”4.24.0″ _module_preset=”default” background_color_phone=”RGBA(255,255,255,0)” background_last_edited=”on|phone” background_enable_color_phone=”on” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_font=”|700|||||||” text_text_color=”#FFFFFF” background_color=”#ea5504″ width=”100%” module_alignment=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|desktop” custom_padding=”10px||||false|false” link_option_url=”https:\/\/kyowakirininternational.com\/global-reporting\/” link_option_url_new_window=”on” border_color_all=”#FFFFFF” global_colors_info=”{}”]<\/p>\n Report Adverse Event [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” z_index=”500″ width=”100%” max_width=”100%” min_height=”100px” height=”100px” overflow-x=”visible” overflow-y=”visible” custom_margin=”||||false|false” custom_padding=”|||25px|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”37″ active_link_color=”#ea5504″ dropdown_menu_bg_color=”#5d6164″ dropdown_menu_line_color=”#ff3300″ dropdown_menu_text_color=”#000000″ dropdown_menu_active_link_color=”#ff3300″ mobile_menu_bg_color=”#b4c0c1″ mobile_menu_text_color=”#000000″ logo=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/KyowaKirin_BrandLogo_colorv2-PhotoRoom-1-1024×216.png” logo_url=”https:\/\/kyowakirininternational.com\/noba-en\/” logo_width=”100%” logo_max_width=”17%” show_search_icon=”on” search_icon_color=”#ea5504″ menu_icon_color=”#ea5504″ logo_max_width_tablet=”35%” logo_max_width_phone=”76%” logo_max_width_last_edited=”on|phone” show_search_icon_tablet=”on” show_search_icon_phone=”on” show_search_icon_last_edited=”on|phone” search_icon_color_tablet=”#ea5504″ search_icon_color_phone=”#ea5504″ search_icon_color_last_edited=”on|phone” _builder_version=”4.25.1″ _module_preset=”default” menu_font=”|600|||||||” menu_text_color=”#5d6164″ menu_font_size=”17px” background_color=”RGBA(255,255,255,0)” custom_css_free_form=”.et_pb_menu__icon.et_pb_menu__search-button {||padding: 2% 2% 2% 1%;||||}” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”90%” max_width=”100%” custom_margin=”-25px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][lwp_divi_breadcrumbs font_icon=”5||divi||400″ link_color=”#5d6164″ separator_color=”#e95505″ current_text_color=”#e95505″ _builder_version=”4.24.0″ _module_preset=”default” module_text_align=”left” background_color=”RGBA(255,255,255,0)” text_orientation=”left” animation_style=”fade” global_module=”1047″ global_colors_info=”{}”][\/lwp_divi_breadcrumbs][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.0″ _module_preset=”default” background_color=”#5d6164″ height=”50px” height_tablet=”100px” height_phone=”140px” height_last_edited=”on|phone” custom_margin=”||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.25.1″ _module_preset=”default” custom_margin=”-40px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”40″ menu_style=”centered” active_link_color=”#ea5504″ dropdown_menu_line_color=”#ea5504″ dropdown_menu_active_link_color=”#ea5504″ mobile_menu_bg_color=”#b4c0c1″ mobile_menu_text_color=”#000000″ menu_icon_color=”#ea5504″ _builder_version=”4.25.1″ _module_preset=”default” menu_text_color=”#FFFFFF” menu_font_size=”15px” background_color=”RGBA(255,255,255,0)” global_colors_info=”{}”][\/et_pb_menu][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ next_background_color=”#FFFFFF” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#e5e5e5″ background_image=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/SeniorLadyGlassesLaughing-1.png” height=”629px” bottom_divider_style=”slant2″ bottom_divider_height=”42px” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” header_font=”|700|||||||” header_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.24.0″ _module_preset=”default” background_color=”RGBA(255,255,255,0)” overflow-x=”visible” overflow-y=”visible” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_testimonial author=”Stacey Minton” job_title=”Senior Vice President (SVP) Head of Corporate Affairs” company_name=”Kyowa Kirin International (KKI)” portrait_url=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/Stacey-Minton-1.png” quote_icon_color=”#FFFFFF” quote_icon_background_color=”#ea5504″ _builder_version=”4.24.3″ _module_preset=”default” body_text_color=”#FFFFFF” author_text_color=”#FFFFFF” position_text_color=”#FFFFFF” company_text_color=”#FFFFFF” background_color=”RGBA(255,255,255,0)” use_background_color_gradient=”on” background_color_gradient_stops=”rgba(234,82,0,0.75) 0%|rgba(234,82,0,0.66) 100%” animation_style=”slide” animation_delay=”200ms” border_color_all=”RGBA(255,255,255,0)” global_colors_info=”{}”]<\/p>\n Acting as a connector and community builder<\/span><\/span>, we work with our stakeholders to identify and connect with patients earlier on their journey, helping them to access the care, treatment and support they need.<\/span><\/span><\/p>\n [\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ next_background_color=”#ea5504″ _builder_version=”4.24.2″ _module_preset=”default” background_color=”#FFFFFF” bottom_divider_style=”curve” bottom_divider_height=”51px” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.24.2″ _module_preset=”default” animation_style=”slide” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” header_font=”|700|||||||” header_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n The Shine A Light on XLH campaign and immersive experience was created to tell the stories of 11 inspiring people living with XLH.<\/p>\n It is space where people living with XLH can recognise their experiences in the stories and lives of others, learn about their condition and access information and support. For more information, please visit the virtual exhibition here<\/a>.<\/span><\/p>\n For more information on the management and treatment of XLH, visit the XLH Link platform here<\/a>.<\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_video src=”https:\/\/www.youtube.com\/watch?v=WdPnCHWlHnc&list=TLGG__TgYRHxKK0wNDAzMjAyNA” _builder_version=”4.24.2″ _module_preset=”default” border_radii=”on|10px|10px|10px|10px” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.2″ _module_preset=”default” animation_style=”slide” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” header_font=”|700|||||||” header_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.25.1″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n In May 2024, Kyowa Kirin proudly announced the publication of ‘Time to Act: A Global Patient-Focused Consensus for Improving the Care of CTCL’, which has been developed in collaboration with patient advocacy groups.<\/p>\n This consensus statement is the inaugural output of the CTCL Global Care Collaborative, a newly established group organised and funded by Kyowa Kirin. Its membership is comprised of patient advocacy groups from across the world and Kyowa Kirin.<\/p>\n The Collaborative is united by a shared mission to reduce the time to an accurate diagnosis and improve the quality of care and support for people living with CTCL. To deliver on this mission, Time to Act calls on healthcare authorities, hospitals, and clinicians to undertake 12 specific actions to help enhance awareness, testing, diagnosis, care, and support for people impacted by CTCL.<\/p>\n Please take a few minutes to read through the full consensus statement, available in English<\/a> and German<\/a>.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ next_background_color=”#FFFFFF” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#ea5504″ bottom_divider_style=”mountains2″ bottom_divider_height=”34px” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” header_font=”|700|||||||” header_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” text_text_color=”#FFFFFF” global_colors_info=”{}”]<\/p>\n Multidisciplinary teams (MDTs) are vital in supporting people living with rare diseases through their diagnosis and care journey. They facilitate better access and more effective delivery of specialist care. For rare diseases like XLH and CTCL, this is vital for those managing such complex diseases.<\/p>\n Kyowa Kirin\u2019s goal is to identify best practices for MDTs in XLH and CTCL across Europe. This is so we can partner with the XLH and CTCL communities to support best-practice sharing, communicate what \u2018good\u2019 care looks like and better understand care delivery and the impact it can have on people\u2019s lives.<\/p>\n Watch the videos below to learn more.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ module_id=”video” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#FFFFFF” animation_style=”slide” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n MDTs in XLH<\/strong><\/p>\n [\/et_pb_text][et_pb_video src=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/XLH-Video-1.mp4″ src_webm=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/XLH-Video-1.mp4″ _builder_version=”4.24.2″ _module_preset=”default” border_radii=”on|10px|10px|10px|10px” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.24.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n MDTs in CTCL<\/strong><\/p>\n [\/et_pb_text][et_pb_video src=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/CTCL-Video-v2-1.mp4″ src_webm=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/03\/CTCL-Video-v2-1.mp4″ _builder_version=”4.24.2″ _module_preset=”default” border_radii=”on|10px|10px|10px|10px” global_colors_info=”{}”][\/et_pb_video][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.26.0″ _module_preset=”default” header_2_font=”|700|||||||” header_2_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n We are committed to ethical and meaningful interactions with patients, care partners, patient advocates and patient advocacy groups. This means ensuring all collaborations between KKI and the patient community reflect the key principles of respect, integrity, independence and transparency.<\/p>\n For more information about how KKI interacts with the patient community, read our Patient Interaction Policy here<\/a>.<\/p>\n [\/et_pb_text][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” header_2_font=”|700|||||||” header_2_text_color=”#ea5504″ global_colors_info=”{}”]<\/p>\n There may be occasions when it may be appropriate for a Kyowa Kirin unlicenced medicine to be provided for a patient using Access to Medicines mechanisms following a request from the responsible Healthcare Professional. This does not include providing medicines as part of a clinical study, humanitarian product donations, other commercial access programs for licensed medicines or commercial supply of free products.<\/p>\n If you are a Healthcare Professional who would like to contact Kyowa Kirin regarding our Access to Medicines mechanisms, please contact us here<\/a>.<\/p>\n Patients cannot make a request for Access to Medicines themselves and will need to contact their Healthcare Professional.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ admin_label=”Section” _builder_version=”4.24.2″ _module_preset=”default” background_color=”#5d6164″ custom_margin=”||||false|false” top_divider_style=”curve” top_divider_color=”#FFFFFF” top_divider_height=”71px” top_divider_repeat=”1x” top_divider_flip=”vertical” top_divider_style_tablet=”” top_divider_style_phone=”none” top_divider_style_last_edited=”on|desktop” global_module=”3452″ saved_tabs=”all” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-50px||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/KKI-Logo-White-PhotoRoom-1-300×86.png” title_text=”KKI Logo White-PhotoRoom” align=”center” _builder_version=”4.24.0″ _module_preset=”default” width=”200px” width_tablet=”15%” width_phone=”50%” width_last_edited=”on|phone” module_alignment=”center” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=”1_2,1_6,1_6,1_6″ _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_padding=”||27px|||” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.2″ _module_preset=”default” text_text_color=”#FFFFFF” header_4_text_color=”#FFFFFF” width=”100%” max_width=”100%” custom_padding=”5px|10px|5px|10px|false|false” border_width_all=”1px” border_color_all=”#FFFFFF” global_colors_info=”{}”]<\/p>\n ADVERSE EVENTS SHOULD BE REPORTED HERE<\/a><\/span><\/p>\n [\/et_pb_text][et_pb_text content_tablet=”” content_phone=”” content_last_edited=”on|phone” module_class=”my-popup2″ _builder_version=”4.25.1″ _module_preset=”default” text_font=”||||||||” text_text_color=”#E02B20″ text_orientation=”center” custom_margin=”||||false|false” custom_margin_tablet=”” custom_margin_phone=”-50px||||false|false” custom_margin_last_edited=”on|desktop” custom_padding=”||||false|false” text_font_size_tablet=”” text_font_size_phone=”” text_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n Click here to search for Kyowa Kirin\u2019s clinical trials<\/a><\/span><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” text_font=”||||||||” text_text_color=”#FFFFFF” text_font_size=”16px” global_colors_info=”{}”]<\/p>\n Press & Media<\/a><\/span> [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” text_font_size=”16px” text_text_color_tablet=”” text_text_color_phone=”” text_text_color_last_edited=”on|desktop” global_colors_info=”{}” text_text_color__hover_enabled=”on|desktop” text_text_color__hover=”#FFFFFF”]<\/p>\n Reporting<\/a><\/span> [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_6″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_padding=”||27px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” header_text_color=”#FFFFFF” header_4_text_color=”#FFFFFF” header_6_text_color=”#FFFFFF” width=”100%” max_width=”100%” global_colors_info=”{}”]<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.24.0″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-50px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.0″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.2″ _module_preset=”default” text_text_color=”#FFFFFF” width=”100%” max_width=”100%” global_colors_info=”{}”]<\/p>\n Copyright \u00a9 Kyowa Kirin International plc. All rights reserved. This website is developed and funded by Kyowa Kirin International plc.<\/span><\/p>\n Head Office Nordics & Baltics: Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.<\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.27.2″ _module_preset=”default” background_color=”#5d6164″ global_colors_info=”{}”][et_pb_row _builder_version=”4.27.2″ _module_preset=”default” width=”70%” max_width=”100%” custom_margin=”-100px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#FFFFFF” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]KKI\/NORD\/KKI\/0046 April 2025[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Acting as a connector and community builder, we work with our stakeholders to identify and connect with patients earlier on their journey, helping them to access the care, treatment and support they need.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":888,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-905","page","type-page","status-publish","hentry"],"yoast_head":"\n![\"\"](\"https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/01\/Link-to-external-1.png\")
<\/p>\nSupporting Patients<\/h1>\n
Shin<\/span>ing<\/span> A Light on XLH<\/span><\/h1>\n
Kyowa Kirin launches the Time to Act global consensus statement in Cutaneous T-Cell Lymphoma (CTCL)<\/h1>\n
![\"\"](\"https:\/\/kyowakirininternational.com\/noba-en\/wp-content\/uploads\/sites\/14\/2024\/05\/CTCL-Global-Care-Collaborative-Logo_Blue-300x164.png\"){kind=logo}
<\/p>\nSupporting Multidisciplinary Care<\/span><\/span><\/h1>\n
Our Patient Interaction Policy<\/h2>\n
Access to Medicines<\/h2>\n
Careers<\/a><\/span><\/p>\n
Responsibility<\/a><\/span><\/p>\nABOUT US<\/a>\u00a0 |\u00a0 CONTACT US<\/a>\u00a0 |\u00a0 NOTICES<\/a>\u00a0 |\u00a0 TERMS OF USE<\/a><\/h4>\n
MODERN SLAVERY ACT<\/a> | THIRD PARTY CODE OF CONDUCT<\/a><\/h4>\n
Kyowa Kirin AB
Torshamnsgatan 39
164 40 Kista
Sweden
Tel: + 46 (8) 50 90 74 10<\/p>\n